Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pulsed field ablation
MedTech
Boston Scientific plans to make ground despite tariff headwinds
Boston Scientific believes it can absorb the hit based on the continuing growth of its franchises in cardiology and urology.
Conor Hale
Apr 24, 2025 12:15pm
Abbott secures European approval for Volt pulsed field ablation
Mar 27, 2025 3:45pm
J&J MedTech restarts Varipulse's US rollout after stroke reports
Feb 18, 2025 11:00am
Boston Scientific clocks $1B+ Farapulse revenue in first year
Feb 5, 2025 11:00am
J&J pauses Varipulse US debut following 4 reports of strokes
Jan 8, 2025 3:00pm
FDA OKs AngioDynamics pulsed field ablation for prostate cancer
Dec 10, 2024 10:43am
